Aztreonam News and Research

RSS
FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Anti-Infective Drugs Advisory Committee to review aztreonam for inhalation solution

Anti-Infective Drugs Advisory Committee to review aztreonam for inhalation solution

European Commission grants conditional marketing authorization for Gilead's Cayston

European Commission grants conditional marketing authorization for Gilead's Cayston

Clinical data on CXA-101 to be presented at ICAAC

Clinical data on CXA-101 to be presented at ICAAC

FOCUS 1 and FOCUS 2 clinical trial results released

FOCUS 1 and FOCUS 2 clinical trial results released

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Corus Pharma selected as a biotech company to watch

Corus Pharma selected as a biotech company to watch